Skip navigation.
ISANH

Order Abstracts Book
ISANH
 

Reversing Aging in Mice is Now Possible

03/17/2022

We don't know if we've ever seen an old mouse, but now we'll never have to.

 

A new study carried out by scientists at the Salk Institute for Biological Studies, Genentech, Inc., and other collaborators, shows that we can effectively reverse the aging process in middle-aged and elderly individuals by toying with epigenetic factors, resetting cells to a younger state.

Their results were published in the journal Nature Aging. There’s only one catch, the individuals in question were all mice.

Over time, our cells undergo changes in epigenetic markers and those changes result in what we experience as aging. Scientists have previously identified four molecules — Oct4, Sox2, Klf4, and cMyc — which are commonly called Yamanaka factors, in biology circles.

Those four molecules are a group of protein transcription factors which play a part in the creation of stem cells. In 2006, Professor Shinya Yamanaka, for whom the molecules take their collective name, used them to create stem cells from adult fibroblasts.

A previous study used those Yamanaka factors to reduce aging and extend lifespan in a group of mice who had a premature aging disease. They were also shown to improve the function of various tissue types in the body. This time around, scientists wanted to know if the therapy could be used safely and effectively in healthy mice, by resetting epigenetic markers in cells.

The mice were broken up into three groups. The first was near the very end of their natural life span and received treatment for only one month. The second was treated over a seven-month period in what we would consider old age. The last group was treated for 10 months, during the mouse equivalent of middle age.

In all three groups, scientists found no negative impact of the treatment. Specifically, there was no increase in the incidence of cancer. In the group which was only treated for a month toward the end of their natural lives, they found no significant improvement or change in the course of ordinary aging. By contrast, the two other groups did exhibit measurable improvements and reversals of the aging process.

The skin, organs, and epigenetic markers of the test animals looked the way they would in younger individuals. They also showed a more robust ability to heal. After injury, the treated animals healed more quickly and with less scarring.

Moreover, the effects became more apparent the longer an individual was treated, suggesting that starting early and maintaining treatment has the highest impact on arresting or reversing the effects of aging. The effects of the treatment appear to stack up over time.

More testing is needed before a similar treatment would be ready even for clinical trials in humans. Hopefully scientists move forward quickly.

We’re not getting any younger. Or are we?

 

Various interesting researches will be presented in Ageing & Longevity 2022. Join us, on the 1st and 2nd of December in Tokyo, to unravel the most recent researches on healthy ageing and longevity.

 

News source

Photo credit: rawpixel.com – www.freepik.com